Results 81 to 90 of about 4,610 (193)
Alendronate-Induced Osteonecrosis of the Jaw in an Elderly Female
Background: In recent years, more and more evidence has demonstrated that a rare symptom, osteonecrosis of the jaw, may be associated with long-term use of bisphosphonates.
Bi-Wei Jan +4 more
doaj +1 more source
Licia Manzon,1 Evaristo Ettorre,1 Giovanni Viscogliosi,1 Stefano Ippoliti,1 Fabio Filiaci,2 Claudio Ungari,2 Giovanni Fratto,1 Alessandro Agrillo2 1Department of Cardiovascular, Respiratory, Nephrologic, Anesthesiologic and Geriatric Sciences ...
Manzon L +7 more
doaj
Bisphosphonate and Nonbisphosphonate-Associated Osteonecrosis of the Jaw [PDF]
Soulafa Almazrooa, Sook‐Bin Woo
openalex +1 more source
Background: Medication-related osteonecrosis of the jaw (MRONJ) is a rare, but significant adverse event primarily associated with the intake of antiresorptive and antiangiogenic medications.
Rahul Mohandas +3 more
doaj +1 more source
Imaging Findings of Bisphosphonates-Associated Osteonecrosis of Jaw: Literature Review and Report of 3 Cases [PDF]
Adela Cristina Lazăr +5 more
openalex +1 more source
Introduction: Medication-related osteonecrosis of the jaw (MRONJ) is an important uncommon complication. Due to its complexity, its prevention requires a multidisciplinary approach, involving physicians and dental clinicians.
Tahereh Padeganeh +3 more
doaj
Malignancy mimicking bisphosphonate-associated osteonecrosis of the jaw: a case series and literature review [PDF]
Thomas Gander +4 more
openalex +1 more source
Medication-related osteonecrosis of the jaw is a rare but severe complication with challenging treatment protocols. Cold atmospheric plasma (CAP) has shown promising effects in wound healing, cell proliferation and viability.
Zahra Rahati Ghuchani +2 more
doaj +1 more source
Bisphosphonate‐Associated Osteonecrosis of the Jaw [PDF]
Sundeep Khosla +23 more
openaire +1 more source

